Table 2.
Quantification of the effects of mutating the Fkh binding site in the ChIPCRM2610 htl enhancer, and the effects of loss of function of CHES-1-like, jumu, or both CHES-1-like and jumu on the activity of the wild-type ChIPCRM2610 htl enhancer